GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia (original) (raw)
Hasle H, Clemmensen IH, Mikkelsen M . Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000; 355: 165–169. ArticleCASPubMed Google Scholar
Hasle H, Abrahamsson J, Arola M, Karow A, O'Marcaigh A, Reinhardt D et al. Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML. Leukemia 2008; 22: 1428–1430. ArticleCASPubMed Google Scholar
Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 2008; 111: 2991–2998. ArticleCASPubMedPubMed Central Google Scholar
Lightfoot J, Hitzler JK, Zipursky A, Albert M, Macgregor PF . Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome. Leukemia 2004; 18: 1617–1623. ArticleCASPubMed Google Scholar
Blink M, Buitenkamp TD, van den Heuvel-Eibrink MM, Danen-van Oorschot AA, de Haas V, Reinhardt D et al. Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia. Leukemia 2011; 25: 1365–1368. ArticleCASPubMed Google Scholar
Klusmann JH, Reinhardt D, Hasle H, Kaspers GJ, Creutzig U, Hahlen K et al. Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome. Leukemia 2007; 21: 1584–1587. ArticleCASPubMed Google Scholar
Kiyoi H, Yamaji S, Kojima S, Naoe T . JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Leukemia 2007; 21: 574–576. ArticleCASPubMed Google Scholar
Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32: 148–152. ArticleCASPubMed Google Scholar
Rylski M, Welch JJ, Chen YY, Letting DL, Diehl JA, Chodosh LA et al. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol 2003; 23: 5031–5042. ArticleCASPubMedPubMed Central Google Scholar
Weiss MJ, Orkin SH . GATA transcription factors: key regulators of hematopoiesis. Exp Hematol 1995; 23: 99–107. CASPubMed Google Scholar
Burda P, Laslo P, Stopka T . The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis. Leukemia 2010; 24: 1249–1257. ArticleCASPubMed Google Scholar
Klusmann JH, Godinho FJ, Heitmann K, Maroz A, Koch ML, Reinhardt D et al. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev 2010; 24: 1659–1672. ArticleCASPubMedPubMed Central Google Scholar
Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH . Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet 2005; 37: 613–619. ArticleCASPubMed Google Scholar
Ge Y, LaFiura KM, Dombkowski AA, Chen Q, Payton SG, Buck SA et al. The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy. Leukemia 2008; 22: 521–529. ArticleCASPubMed Google Scholar
Stankiewicz MJ, Crispino JD . AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL. Leukemia 2013; 27: 1339–1347. ArticleCASPubMedPubMed Central Google Scholar
Harigae H, Takahashi S, Suwabe N, Ohtsu H, Gu L, Yang Z et al. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 1998; 3: 39–50. ArticleCASPubMed Google Scholar
Hirasawa R, Shimizu R, Takahashi S, Osawa M, Takayanagi S, Kato Y et al. Essential and instructive roles of GATA factors in eosinophil development. J Exp Med 2002; 195: 1379–1386. ArticleCASPubMedPubMed Central Google Scholar
Takahashi S, Komeno T, Suwabe N, Yoh K, Nakajima O, Nishimura S et al. Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. Blood 1998; 92: 434–442. CASPubMed Google Scholar
Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 2002; 195: 1387–1395. ArticleCASPubMedPubMed Central Google Scholar
Nei Y, Obata-Ninomiya K, Tsutsui H, Ishiwata K, Miyasaka M, Matsumoto K et al. GATA-1 regulates the generation and function of basophils. Proc Natl Acad Sci USA 2013; 110: 18620–18625. ArticleCASPubMedPubMed Central Google Scholar
Du J, Stankiewicz MJ, Liu Y, Xi Q, Schmitz JE, Lekstrom-Himes JA et al. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem 2002; 277: 43481–43494. ArticleCASPubMed Google Scholar
Uhm TG, Kim BS, Chung IY . Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol Res 2012; 4: 68–79. ArticleCASPubMed Google Scholar
Heyworth C, Pearson S, May G, Enver T . Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J 2002; 21: 3770–3781. ArticleCASPubMedPubMed Central Google Scholar
Eguchi M, Sakaibara H, Suda J, Ozawa T, Hayashi Y, Sato T et al. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome. Br J Haematol 1989; 73: 315–322. ArticleCASPubMed Google Scholar
Miyauchi J, Ito Y, Tsukamoto K, Takahashi H, Ishikura K, Sugita K et al. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1. Br J Haematol 2010; 148: 898–909. ArticlePubMed Google Scholar
Suda T, Suda J, Miura Y, Hayashi Y, Eguchi M, Tadokoro K et al. Clonal analysis of basophil differentiation in bone marrow cultures from a Down's syndrome patient with megakaryoblastic leukemia. Blood 1985; 66: 1278–1283. CASPubMed Google Scholar
Stankov MV, El Khatib M, Kumar Thakur B, Heitmann K, Panayotova-Dimitrova D, Schoening J et al. Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia 2014; 28: 577–588. ArticleCASPubMed Google Scholar
Emmrich S, Henke K, Hegermann J, Ochs M, Reinhardt D, Klusmann JH . miRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol 2012; 91: 1673–1684. ArticleCASPubMed Google Scholar
Weber K, Bartsch U, Stocking C, Fehse B . A multicolor panel of novel lentiviral ‘gene ontology’ (LeGO) vectors for functional gene analysis. Mol Ther 2008; 16: 698–706. ArticleCASPubMed Google Scholar
Klusmann JH, Li Z, Bohmer K, Maroz A, Koch ML, Emmrich S et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 2010; 24: 478–490. ArticleCASPubMedPubMed Central Google Scholar
Hennig C, Adams N, Hansen G . A versatile platform for comprehensive chip-based explorative cytometry. Cytometry A 2009; 75: 362–370. ArticlePubMed Google Scholar
Kim J, Cantor AB, Orkin SH, Wang J . Use of in vivo biotinylation to study protein-protein and protein-DNA interactions in mouse embryonic stem cells. Nat Protoc 2009; 4: 506–517. ArticleCASPubMed Google Scholar
Xu J, Shao Z, Glass K, Bauer DE, Pinello L, Van Handel B et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev Cell 2012; 23: 796–811. ArticleCASPubMedPubMed Central Google Scholar
Rodriguez P, Braun H, Kolodziej KE, de Boer E, Campbell J, Bonte E et al. Isolation of transcription factor complexes by in vivo biotinylation tagging and direct binding to streptavidin beads. Methods Mol Biol 2006; 338: 305–323. CASPubMed Google Scholar
Hamaguchi-Tsuru E, Nobumoto A, Hirose N, Kataoka S, Fujikawa-Adachi K, Furuya M et al. Development and functional analysis of eosinophils from murine embryonic stem cells. Br J Haematol 2004; 124: 819–827. ArticlePubMed Google Scholar
Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P et al. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA 2006; 103: 3339–3344. ArticleCASPubMedPubMed Central Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550. ArticleCASPubMedPubMed Central Google Scholar
Nakajima T, Matsumoto K, Suto H, Tanaka K, Ebisawa M, Tomita H et al. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 2001; 98: 1127–1134. ArticleCASPubMed Google Scholar
Toki T, Kanezaki R, Adachi S, Fujino H, Xu G, Sato T et al. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia. Leukemia 2009; 23: 95–103. ArticleCASPubMed Google Scholar
Bohn G, Allroth A, Brandes G, Thiel J, Glocker E, Schaffer AA et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007; 13: 38–45. ArticleCASPubMed Google Scholar
Kulessa H, Frampton J, Graf T . GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 1995; 9: 1250–1262. ArticleCASPubMed Google Scholar
Tanaka H, Matsumura I, Nakajima K, Daino H, Sonoyama J, Yoshida H et al. GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1. Blood 2000; 95: 1264–1273. CASPubMed Google Scholar
Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M, Suda T . Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation. Blood 1998; 91: 450–457. CASPubMed Google Scholar
Voehringer D, Shinkai K, Locksley RM . Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004; 20: 267–277. ArticleCASPubMed Google Scholar
Dyer KD, Garcia-Crespo KE, Percopo CM, Sturm EM, Rosenberg HF . Protocols for identifying, enumerating, and assessing mouse eosinophils. Methods Mol Biol 2013; 1032: 59–77. ArticleCASPubMed Google Scholar
Voehringer D, Van Rooijen N, Locksley RM . Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages. J Leukoc Biol 2007; 81: 1434–1444. ArticleCASPubMed Google Scholar
Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 2002; 16: 245–256. ArticleCASPubMedPubMed Central Google Scholar
Kadri Z, Shimizu R, Ohneda O, Maouche-Chretien L, Gisselbrecht S, Yamamoto M et al. Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol 2009; 7: e1000123. ArticlePubMedPubMed Central Google Scholar
Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, Kang YA et al. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 2009; 36: 667–681. ArticleCASPubMedPubMed Central Google Scholar
Yu M, Riva L, Xie H, Schindler Y, Moran TB, Cheng Y et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell 2009; 36: 682–695. ArticleCASPubMedPubMed Central Google Scholar
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011; 146: 904–917. ArticleCASPubMedPubMed Central Google Scholar
Thalmeier K, Synovzik H, Mertz R, Winnacker EL, Lipp M . Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev 1989; 3: 527–536. ArticleCASPubMed Google Scholar
Sears R, Ohtani K, Nevins JR . Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 1997; 17: 5227–5235. ArticleCASPubMedPubMed Central Google Scholar
Mateyak MK, Obaya AJ, Sedivy JM . c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19: 4672–4683. ArticleCASPubMedPubMed Central Google Scholar
Hollanda LM, Lima CS, Cunha AF, Albuquerque DM, Vassallo J, Ozelo MC et al. An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat Genet 2006; 38: 807–812. ArticleCASPubMed Google Scholar
Worth LL, Zipursky A, Christensen H, Tubergen D . Transient leukemia with extreme basophilia in a phenotypically normal infant with blast cells containing a pseudodiploid clone, 46,XY i(21)(q10). J Pediatr Hematol Oncol 1999; 21: 63–66. ArticleCASPubMed Google Scholar
Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF . Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J Exp Med 1995; 182: 49–57. ArticleCASPubMed Google Scholar